MeSH term | MeSH ID | Detail |
---|---|---|
Body Weight | D001835 | 333 associated lipids |
Otitis Media | D010033 | 12 associated lipids |
Whooping Cough | D014917 | 6 associated lipids |
Fecal Impaction | D005244 | 1 associated lipids |
Total
4
ERYTHROMYCIN ESTOLATE is a lipid of Polyketides (PK) class.
We collected disease MeSH terms mapped to the references associated with ERYTHROMYCIN ESTOLATE
MeSH term | MeSH ID | Detail |
---|---|---|
Body Weight | D001835 | 333 associated lipids |
Otitis Media | D010033 | 12 associated lipids |
Whooping Cough | D014917 | 6 associated lipids |
Fecal Impaction | D005244 | 1 associated lipids |
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Langley JM et al. | Azithromycin is as effective as and better tolerated than erythromycin estolate for the treatment of pertussis. | 2004 | Pediatrics | pmid:15231980 |
Snellman LW et al. | Duration of positive throat cultures for group A streptococci after initiation of antibiotic therapy. | 1993 | Pediatrics | pmid:8502522 |
Halperin SA et al. | Seven days of erythromycin estolate is as effective as fourteen days for the treatment of Bordetella pertussis infections. | 1997 | Pediatrics | pmid:9200361 |
Halperin SA et al. | A randomized, placebo-controlled trial of erythromycin estolate chemoprophylaxis for household contacts of children with culture-positive bordetella pertussis infection. | 1999 | Pediatrics | pmid:10506267 |
Hoppe JE | Comparison of erythromycin estolate and erythromycin ethylsuccinate for treatment of pertussis. The Erythromycin Study Group. | 1992 | Pediatr. Infect. Dis. J. | pmid:1565532 |
Torre D et al. | Erythromycin estolate for treatment of pertussis. | 1986 Nov-Dec | Pediatr Infect Dis | pmid:3797311 |
Derrick CW et al. | Erythromycin in the treatment of streptococcal infections. | 1986 Jan-Feb | Pediatr Infect Dis | pmid:3945572 |
Ginsburg CM | Pharmacology of erythromycin in infants and children. | 1986 Jan-Feb | Pediatr Infect Dis | pmid:3753798 |
Ginsburg CM | A prospective study on the incidence of liver function abnormalities in children receiving erythromycin estolate, erythromycin ethylsuccinate or penicillin V for treatment of pneumonia. | 1986 Jan-Feb | Pediatr Infect Dis | pmid:3080735 |
Griffith RS | Pharmacology of erythromycin in adults. | 1986 Jan-Feb | Pediatr Infect Dis | pmid:3511455 |